2 min reading time
If you’re doing business in Europe, I recommend you download this free report from ICON plc at https://medgroup.biz/ICON-MDR There’s way too much for me to summarize in the space LinkedIn allows. Here are my oversimplified observations. • European approvals are going to cost you more and take longer. • Certification will be required for about 90% of all IVDs, up from 10% today. • Your products may be reclassified (IVDs into four classes, A through D, outlined in report)… • … and recertified, and will increase costly clinical monitoring and evidence generation. • Notified Bodies are (already) overwhelmed. Get in queue immediately. (See our group discussion, “Need an NB? Good Luck! at https://medgroup.biz/NB-luck.) • Defective devices will cost you more and will require insurance and greater scrutiny of outsourced production. • Most devices and IVDs will require post-market surveillance and performance assessments. • Regulations may be applied outside the EU and in the UK after Brexit. • Pre-approval clinical studies rather than equivalency statements for many new implants. • The “medical device definition” will now include devices for support of conception and products specifically intended for cleaning, disinfection, or sterilisation. • Importers, distributors, and authorized reps must maintain records of devices through new UDI codes. • Something about EUDAMED submissions that went over my head. (Just sayin’.) Download the report at https://medgroup.biz/ICON-MDR. It will save you a lot of time researching this on your own; it tells you what you need to know. Thanks for preparing it and sharing with the group, ICON. +++ Free Webinar today: Computational Modeling for Medical Device Development and FDA Certification at https://medgroup.biz/comp-modeling +++ Probably will create a book out of this. Add your voice: https://medgroup.biz/collective-wisdom +++ Make it a great week. Joe Hage Joe Hage Joe Hage Robert Mogel Ken Ludzack Beatrice Hamblin Bruce Beardsell John E. Hamm Ken Buroker Marked as spam
|